EricWhitmanMD

General Surgery • Morristown, NJ

Endocrine, Melanoma, Surgical Oncology (Other than Breast), Clinical Informatics

Medical Director, Atlantic Health System Cancer Care and Director, Atlantic Melanoma Center

Join to view full profile

Dr. Whitman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Whitman's full profile

Already have an account?

Office
100 Madison Avenue
Suite 3502
Morristown, NJ 07962
Is this information wrong?

Summary

Dr. Eric Whitman is a general surgeon in Morristown, NJ and is affiliated with multiple hospitals in the area, including Morristown Medical Center, Overlook Medical Center, and Chilton Medical Center. He received his medical degree from Pennsylvania State University College of Medicine and has been in practice 32 years. He specializes in endocrine, vascular surgery, melanoma, and surgical oncology (other than breast) and is experienced in endocrine surgery, surgical oncology (non-breast), tumor immunotherapy, melanoma and cutaneous malignancies, and t-cell adoptive tumor therapy. He has more than 20 publications and over 500 citings.

Education & Training

National Cancer InstituteFellowship, Senior Staff Fellow, Surgery Branch, 1991 - 1992
Penn State Milton S Hershey Medical CenterResidency, Surgery, 1985 - 1991
Penn State Milton S. Hershey Medical CenterFellowship, Surgical Research, 1987 - 1988
Pennsylvania State University College of MedicineClass of 1985

Certifications & Licensure

NJ State Medical License 2004 - 2025
MD State Medical License 1992 - 1993
American Board of Surgery Surgery

Awards, Honors, & Recognition

Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2022
Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2022
Top Doctors: New York Metro Area Castle Connolly, 2009-2022
NJ.com Top Doctors Castle Connolly, 2009
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Sep 19
Active, not recruiting
Phase 2
RTA 408 Capsules in Patients With Melanoma - REVEAL Start of enrollment: 2014 Oct 31
Completed
Phase 1, Phase 2
PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma Start of enrollment: 2015 Apr 01
Terminated
Phase 3
Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI) Start of enrollment: 2015 May 05
Completed
Phase 1
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer Start of enrollment: 2013 Feb 01
Recruiting
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 Start of enrollment: 2020 May 13
Active, not recruiting
Phase 1, Phase 2
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise Start of enrollment: 2020 Oct 14
Terminated
Phase 2
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells. Start of enrollment: 2021 Feb 26
Recruiting
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC Start of enrollment: 2020 Sep 16
Recruiting
Phase 1, Phase 2
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab Start of enrollment: 2017 Sep 20
Recruiting
Phase 2
ITIL-168 in Advanced Melanoma Start of enrollment: 2021 Oct 07
Terminated
Phase 2
Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE Start of enrollment: 2020 Sep 04
Active, not recruiting
Phase 4
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Start of enrollment: 2017 Jan 30
Active, not recruiting
Phase 2
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial Start of enrollment: 2018 Nov 15
Suspended
Phase 3
A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma Start of enrollment: 2021 Oct 19
Active, not recruiting
Phase 3
A Study of DF6002 Alone and in Combination With Nivolumab Start of enrollment: 2020 Jul 13
Recruiting
Phase 1, Phase 2
A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment Start of enrollment: 2021 Dec 09
Completed
Phase 1
A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Start of enrollment: 2019 Dec 12
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
John Cafardi, Carole Miller, Howard Terebelo, Chad Tewell, Sadia Benzaquen, David Park, Pamela Egan, Daniel Lebovic, Kristen Pettit, Eric Whitman, Douglas Tremblay, Jo...> ;JAMA Network Open. 2022 Dec 1
RE: More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 ...
Eric D Whitman, J Michael Guenther> ;Journal of Surgical Oncology. 2022 Jun 1
10 citations
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial.
Cohen, E., Nabell, L., Wong, D., Day, T., Daniels, G., Milhem, M., Deva, S., Jameson, M., Guntinas-Lichius, O., Almubarak, M., Strother, M., Whitman, E., Chisamore, M....> ;Clinical Cancer Research. 2022 Mar 15
31 citations
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.
Robert H.I. Andtbacka, Brendan D. Curti, Gregory A. Daniels, Sigrun Hallmeyer, Eric D. Whitman, Jose Lutzky, Lynn E. Spitler, Karl Zhou, Praveen K. Bommareddy, Mark Gr...> ;Journal of Clinical Oncology. 2021 Aug 31
96 citations
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma.
Amod A. Sarnaik, Omid Hamid, Nikhil I. Khushalani, Karl D. Lewis, Theresa Medina, Harriet M. Kluger, Sajeve Samuel Thomas, Evidio Domingo-Musibay, Anna C. Pavlick, Eri...> ;Journal of Clinical Oncology. 2021 May 12
213 citations
Unbiased Screens Show CD8 + T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.
Andrew P. Ferretti, Tomasz Kula, Yifan Wang, Dalena M.V. Nguyen, Adam Weinheimer, Garrett S. Dunlap, Qikai Xu, Nancy Nabilsi, Candace R. Perullo, Alexander W. Cristofa...> ;Immunity. 2020 Nov 17
7 citations
Outcomes of retreatment with anti-PD-1 monotherapy after response to first course in patients with cutaneous melanoma.
Eric D. Whitman, Emilie Scherrer, Wanmei Ou, Clemens Krepler> ;Future Oncology. 2020 May 15
23 citations
Real-world experience with pembrolizumab in patients with advanced melanoma: A large retrospective observational study.
Frank Xiaoqing Liu, Wanmei Ou, Scott J. Diede, Eric D. Whitman> ;Medicine. 2019 Jul 1
24 citations
Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practices.
Eric D. Whitman, Frank Xiaoqing Liu, Xiting Cao, Scott J. Diede, Amin Haiderali, Amy P. Abernethy> ;Future Oncology. 2019 Feb 1
51 citations
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Ryan J. Sullivan, Michael B. Atkins, John M. Kirkwood, Sanjiv S. Agarwala, Joseph I. Clark, Marc S. Ernstoff, Leslie A. Fecher, Thomas F. Gajewski, Brian R. Gastman, D...> ;Journal for Immunotherapy of Cancer. 2018 May 30
139 citations
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Michele Maio, Karl D. Lewis, Lev V. Demidov, Mario Mandalà, Igor Bondarenko, Paolo A. Ascierto, Christopher Herbert, Andrzej Mackiewicz, Piotr Rutkowski, Alexander Gum...> ;The Lancet. Oncology. 2018 Apr 1
28 citations
Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB-IVM1c melanoma.
Jason Chesney, Sanjay Awasthi, Brendan D. Curti, Laura F. Hutchins, Gerald P. Linette, Pierre L. Triozzi, Marcus C.B. Tan, Russell E. Brown, John Nemunaitis, Eric D. W...> ;Melanoma Research. 2018 Feb 1
15 citations
Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E
Sigrun Hallmeyer, Rene Gonzalez, David H. Lawson, Lee D. Cranmer, Gerald P. Linette, Igor Puzanov, Bret Taback, C. Lance Cowey, Antoni Ribas, Gregory A. Daniels, Timot...> ;Melanoma Research. 2017 Dec 1
91 citations
Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Met...
Michael S. Hughes, Jonathan S. Zager, Mark B. Faries, H. Richard Alexander, Richard E. Royal, Bradford J. Wood, Junsung Choi, Kevin McCluskey, Eric D. Whitman, Sanjiv ...> ;Annals of Surgical Oncology. 2016 Apr 1
69 citations
Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study
Howard L. Kaufman, Thomas Amatruda, Tony R. Reid, Rene Gonzalez, John A. Glaspy, Eric D. Whitman, Kevin J. Harrington, John Nemunaitis, Andrew Zloza, Michael Wolf, Nei...> ;Journal for Immunotherapy of Cancer. 2016 Mar 15
20 citations
Variations in time to receiving first surgical treatment for breast cancer as a function of racial/ethnic background: a cohort study
Rami Bustami, Daniel B. Shulkin, Nancy O'Donnell, Eric D. Whitman> ;JRSM Open. 2014 Jul 1
15 citations
Role of sentinel lymphadenectomy in thin cutaneous melanomas with positive deep margins on initial biopsy.
Vadim P. Koshenkov, Daniel B. Shulkin, Rami Bustami, Aaron H. Chevinsky, Eric D. Whitman> ;Journal of Surgical Oncology. 2012 Sep 15
69 citations
Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database
Richard L. White, Gregory D. Ayers, Virginia H. Stell, Shouluan Ding, Jeffrey E. Gershenwald, Jonathan C. Salo, Barbara A. Pockaj, Richard Essner, Mark B. Faries, Kim ...> ;Annals of Surgical Oncology. 2011 Jun 7
601 citations
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
Douglas J. Schwartzentruber, David H. Lawson, Jon M. Richards, Robert M. Conry, Donald M. Miller, Jonathan S. Treisman, Fawaz Gailani, Lee B. Riley, Kevin C. Conlon, B...> ;The New England Journal of Medicine. 2011 Jun 2
118 citations
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma.
Karl D. Lewis, Wolfram E. Samlowski, John Harris Ward, Joseph P. Catlett, Lee D. Cranmer, John M. Kirkwood, David H. Lawson, Eric Whitman, Rene Gonzalez> ;Investigational New Drugs. 2011 Feb 1
59 citations
A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma.
Agop Y. Bedikian, Jon M. Richards, Dmitri D. Kharkevitch, Michael B. Atkins, Eric D. Whitman, Rene Gonzalez> ;Melanoma Research. 2010 Jun 1
443 citations
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastati...
Neil Senzer, Howard L. Kaufman, Thomas Amatruda, Mike Nemunaitis, Tony Reid, Gregory Daniels, Rene Gonzalez, John A. Glaspy, Eric D. Whitman, Kevin J. Harrington, Howa...> ;Journal of Clinical Oncology. 2009 Dec 1
188 citations
Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melano...
A. Testori, Jon M. Richards, Eric D. Whitman, G. Bruce Mann, Jose Lutzky, Luis H. Camacho, Giorgio Parmiani, Giulio Tosti, John M. Kirkwood, Axel Hoos, Lianng Yuh, Gup...> ;Journal of Clinical Oncology. 2008 Feb 20
59 citations
Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous ...
Malcolm S. Mitchell, Judith Abrams, John A. Thompson, Mohammed Kashani-Sabet, Ronald C. DeConti, Wen-Jen Hwu, Michael B. Atkins, Eric D. Whitman, Marc S. Ernstoff, Fra...> ;Journal of Clinical Oncology. 2007 May 20
Join now to see all

Other

IrAEs in Patients With Melanoma
Eric Whitman, MD
https://immunosym.org/daily-news/iraes-patients-melanoma
1/18/2018

Press Mentions

Atlantic Health System’s Morristown Medical Center Earns National Pancreas Foundation Center DesignationFebruary 21st, 2023
Cherry Promoted to 2 New Medical Director Roles at Atlantic HealthFebruary 24th, 2022
Atlantic Health System Taps New Hematology DirectorFebruary 23rd, 2022
Join now to see all